By Jeff Overley ( November 4, 2013, 7:46 PM EST) -- Johnson & Johnson's $2.2 billion deal Monday to end a vast False Claims Act investigation will probably be one of the last monster settlements under a long-running crusade against off-label marketing, with other drugmakers having already learned costly lessons and the federal government setting its sights on new sectors, attorneys say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.